Health Care: Health Services

AcelRx Pharmaceuticals Inc (ACRX: NASDAQ)

$6.96 0.44 | 6.75%
07/31/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 29.50M 2.39M 1.07M 0.00
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 29.50M 2.39M 1.07M 0.00
Selling, General, and Administrative Expenses 9.88M 7.20M 6.80M 3.99M
Research & Development 26.29M 24.91M 13.62M 8.19M
Operating Income before D & A (EBITDA) -6.67M -29.71M -19.35M -12.19M
Depreciation & Amortization 795.00K 985.00K 708.00K 479.00K
Interest Income 0.00 0.00 52.00K 4.00K
Other Income - Net -15.24M -1.37M 1.51M -765.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -22.70M -32.06M -18.50M -13.43M
Interest Expense 1.52M 2.28M 2.31M 1.40M
Pre-Tax Income -24.22M -34.35M -20.81M -14.82M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -23.43M -33.36M -20.10M -14.34M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -23.43M -33.36M -20.10M -14.34M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -23.43M -33.36M -20.10M -14.34M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-23.43M -33.36M -20.10M -14.34M
Preferred Dividends
Net Income Available To Common -23.43M -33.36M -20.10M -14.34M
Basic EPS from Continuing Ops. -0.59 -1.51 -1.16 -21.84
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.59 -1.51 -1.16 -21.84
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.59 -1.51 -1.16 -21.84
Basic Normalized Net Income/Share -0.59 -1.51 -1.16 -21.84
EPS fr Continuing Ops. -0.59 -1.51 -1.16 -21.84
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.59 -1.51 -1.16 -21.84
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.59 -1.51 -1.16 -21.84
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.59 -1.51 -1.16 -21.84
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ACRX

Latest ACRX Headlines from TheStreet

More Financial News for ACRX

Press Releases for ACRX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter